Insiders Harrow, Inc.

Equities

Market Closed - OTC Markets Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
12.07 ^USD	+4.05%		+15.06%	+7.77%

May. 13	Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours	MT
Apr. 11	Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target	MT

Harrow, Inc. Announces Board of Director Appointments	Jan. 29	CI
Harrow, Inc. Appoints John P. Saharek as President and Chief Executive Officer of its ImprimisRx Division	Jan. 03	CI
Harrow, Inc. Announces Board and Committee Changes	Nov. 03	CI
Harrow Health, Inc. has Changed its Name to Harrow, Inc	23-09-29	CI
Insider Buy: Harrow Health	23-08-15	MT
Harrow Health, Inc. Announces Appointment of Mark Mannebach as Head of Regulatory Affairs and Pharmacovigilance	23-03-06	CI
Insider Buy: Harrow Health	22-12-23	MT
Insider Buy: Harrow Health	22-12-23	MT
Insider Sell: Harrow Health	22-10-04	MT
Akari Therapeutics Names Melissa Bradford-Klug COO	22-06-13	MT
Harrow Health, Inc. Announces Management Changes	22-03-31	CI
Harrow Health, Inc Announces Board Changes	21-08-23	CI
Insider Trends: Insider Purchase of Harrow Health Stock Continues 90-Day Positive Trend	21-08-19	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	21-07-22	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	21-06-22	MT
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Harrow Health	21-05-21	MT
Insider Trends: Harrow Health Insider 90-Day Buying Trend Prolonged with Purchase	20-12-22	MT
Harrow Health Appoints Larry Van Horn to its Board of Directors	20-09-30	CI
Harrow Health, Inc. Announces Board and Committee Changes	20-03-17	CI
Harrow Health, Inc. Announces Launch of Mayfield Pharmaceuticals; to Appoint Melissa Bradford-Klug to Lead Mayfield Pharmaceuticals, Inc	19-07-31	CI

No results for this search